Closing Bell Recap: FibroGen Inc (FGEN) Ends at 1.10, Reflecting a 6.80 Upturn

Those aiming for above-average market returns often engage in the meticulous process of stock picking. Choosing the right stocks can make a substantial difference in your wealth.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free
Sponsored

FibroGen Inc (NASDAQ: FGEN) closed the day trading at $1.10 up 6.80% from the previous closing price of $1.03. In other words, the price has increased by $6.80 from its previous closing price. On the day, 1.35 million shares were traded. FGEN stock price reached its highest trading level at $1.13 during the session, while it also had its lowest trading level at $1.01.

Ratios:

For a better understanding of FGEN, let’s look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 1.27 and its Current Ratio is at 1.41.

Upgrades & Downgrades

In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, BofA Securities on August 08, 2023, Downgraded its rating to Underperform and sets its target price to $2 from $4 previously.

Insider Transactions:

The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Jun 12 ’24 when Adib Deyaa bought 22,123 shares for $1.17 per share. The transaction valued at 25,884 led to the insider holds 82,123 shares of the business.

Wettig Thane bought 50,000 shares of FGEN for $95,470 on Mar 07 ’24. The CEO now owns 470,178 shares after completing the transaction at $1.91 per share. On Sep 01 ’23, another insider, Henderson Jeffrey William, who serves as the Director of the company, sold 2,000 shares for $1.03 each. As a result, the insider received 2,060 and left with 28,866 shares of the company.

Valuation Measures:

Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, FGEN now has a Market Capitalization of 109422944 and an Enterprise Value of 141191936. For the stock, the TTM Price-to-Sale (P/S) ratio is 0.65. Its current Enterprise Value per Revenue stands at 0.843 whereas that against EBITDA is -0.586.

Stock Price History:

The Beta on a monthly basis for FGEN is 0.73, which has changed by -0.9314642 over the last 52 weeks, in comparison to a change of 0.2586832 over the same period for the S&P500. Over the past 52 weeks, FGEN has reached a high of $17.46, while it has fallen to a 52-week low of $0.33. The 50-Day Moving Average of the stock is -7.51%, while the 200-Day Moving Average is calculated to be -5.09%.

Shares Statistics:

Over the past 3-months, FGEN traded about 2.35M shares per day on average, while over the past 10 days, FGEN traded about 1277350 shares per day. A total of 98.77M shares are outstanding, with a floating share count of 92.39M. Insiders hold about 7.12% of the company’s shares, while institutions hold 61.93% stake in the company. Shares short for FGEN as of 1715731200 were 7383409 with a Short Ratio of 3.18, compared to 1713139200 on 5429224. Therefore, it implies a Short% of Shares Outstanding of 7383409 and a Short% of Float of 8.75.

Most Popular